Bumped Kinase Inhibitors as therapy for apicomplexan parasitic diseases: lessons learned.

Choi, Ryan; Hulverson, Matthew A; Huang, Wenlin; Vidadala, Rama S R; Whitman, Grant R; Barrett, Lynn K; Schaefer, Deborah A; Betzer, Dana P; Riggs, Michael W; Doggett, J Stone; Hemphill, Andrew; Ortega-Mora, Luis Miguel; McCloskey, Molly C; Arnold, Samuel L M; Hackman, Robert C; Marsh, Kennan C; Lynch, James J; Freiberg, Gail M; Leroy, Bruce E; Kempf, Dale J; ... (2020). Bumped Kinase Inhibitors as therapy for apicomplexan parasitic diseases: lessons learned. International journal for parasitology, 50(5), pp. 413-422. Elsevier 10.1016/j.ijpara.2020.01.006

[img] Text
Choi_et_al_Int_J_Parasitol.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (558kB)

Bumped Kinase Inhibitors, targeting Calcium-dependent Protein Kinase 1 in apicomplexan parasites with a glycine gatekeeper, are promising new therapeutics for apicomplexan diseases. Here we will review advances, as well as challenges and lessons learned regarding efficacy, safety, and pharmacology that have shaped our selection of pre-clinical candidates.

Item Type:

Journal Article (Review Article)

Division/Institute:

05 Veterinary Medicine > Department of Infectious Diseases and Pathobiology (DIP) > Institute of Parasitology

Graduate School:

Graduate School for Cellular and Biomedical Sciences (GCB)

UniBE Contributor:

Hemphill, Andrew

Subjects:

600 Technology > 630 Agriculture

ISSN:

1879-0135

Publisher:

Elsevier

Language:

English

Submitter:

Andrew Hemphill

Date Deposited:

17 Feb 2021 14:47

Last Modified:

05 Dec 2022 15:47

Publisher DOI:

10.1016/j.ijpara.2020.01.006

PubMed ID:

32224121

Uncontrolled Keywords:

Apicomplexa Bumped Kinase Inhibitor Calcium-dependent Protein Kinases Cryptosporidium Gatekeeper Neospora Sarcocystis Toxoplasma

BORIS DOI:

10.48350/152374

URI:

https://boris.unibe.ch/id/eprint/152374

Actions (login required)

Edit item Edit item
Provide Feedback